Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
August 2015
|
| In: |
Clinical lymphoma, myeloma & leukemia
Year: 2015, Volume: 15, Issue: 8, Pages: 458-463 |
| ISSN: | 2152-2669 |
| DOI: | 10.1016/j.clml.2015.03.008 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.clml.2015.03.008
|
| Author Notes: | Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho, Mathias Witzens-Harig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1551913054 | ||
| 003 | DE-627 | ||
| 005 | 20230426141209.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170119s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clml.2015.03.008 |2 doi | |
| 035 | |a (DE-627)1551913054 | ||
| 035 | |a (DE-576)48191305X | ||
| 035 | |a (DE-599)BSZ48191305X | ||
| 035 | |a (OCoLC)1340955669 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rohlfing, Sarah |e VerfasserIn |0 (DE-588)1123737908 |0 (DE-627)877384754 |0 (DE-576)481912622 |4 aut | |
| 245 | 1 | 0 | |a Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases |c Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho, Mathias Witzens-Harig |
| 264 | 1 | |c August 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.01.2017 | ||
| 700 | 1 | |a Aurich, Matthias |d 1983- |e VerfasserIn |0 (DE-588)1059231417 |0 (DE-627)798165715 |0 (DE-576)415235421 |4 aut | |
| 700 | 1 | |a Schöning, Tilman |d 1972- |e VerfasserIn |0 (DE-588)140330836 |0 (DE-627)617702489 |0 (DE-576)316456705 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical lymphoma, myeloma & leukemia |d Amsterdam [u.a.] : Elsevier, 2010 |g 15(2015), 8, Seite 458-463 |h Online-Ressource |w (DE-627)620142014 |w (DE-600)2540998-0 |w (DE-576)358408776 |x 2152-2669 |7 nnas |a Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases |
| 773 | 1 | 8 | |g volume:15 |g year:2015 |g number:8 |g pages:458-463 |g extent:6 |a Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clml.2015.03.008 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170119 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 140330836 |a Schöning, Tilman |m 140330836:Schöning, Tilman |d 910000 |e 910000PS140330836 |k 0/910000/ |p 3 | ||
| 998 | |g 1059231417 |a Aurich, Matthias |m 1059231417:Aurich, Matthias |d 910000 |d 910100 |e 910000PA1059231417 |e 910100PA1059231417 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1123737908 |a Rohlfing, Sarah |m 1123737908:Rohlfing, Sarah |d 910000 |d 910100 |e 910000PR1123737908 |e 910100PR1123737908 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1551913054 |e 2950849768 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1551913054","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"August 2015"}],"name":{"displayForm":["Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho, Mathias Witzens-Harig"]},"person":[{"display":"Rohlfing, Sarah","given":"Sarah","family":"Rohlfing","role":"aut"},{"role":"aut","given":"Matthias","display":"Aurich, Matthias","family":"Aurich"},{"given":"Tilman","display":"Schöning, Tilman","family":"Schöning","role":"aut"},{"role":"aut","display":"Ho, Anthony Dick","given":"Anthony Dick","family":"Ho"},{"family":"Witzens-Harig","display":"Witzens-Harig, Mathias","given":"Mathias","role":"aut"}],"language":["eng"],"title":[{"title":"Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases","title_sort":"Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseases"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1551913054"],"doi":["10.1016/j.clml.2015.03.008"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"titleAlt":[{"title":"Clinical lymphoma, myeloma and leukemia"}],"language":["eng"],"recId":"620142014","disp":"Nonpegylated liposomal doxorubicin as a component of R-CHOP is an effective and safe alternative to conventional doxorubicin in the treatment of patients with diffuse large B-Cell lymphoma and preexisting cardiac diseasesClinical lymphoma, myeloma & leukemia","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["10.2010 -"],"title":[{"title_sort":"Clinical lymphoma, myeloma & leukemia","title":"Clinical lymphoma, myeloma & leukemia"}],"origin":[{"dateIssuedDisp":"2010-","publisher":"Elsevier ; CIG Media Group","publisherPlace":"Amsterdam [u.a.] ; Dallas, Tex.","dateIssuedKey":"2010"}],"note":["Gesehen am 04.02.20"],"part":{"extent":"6","issue":"8","text":"15(2015), 8, Seite 458-463","volume":"15","year":"2015","pages":"458-463"},"id":{"eki":["620142014"],"issn":["2152-2669"],"zdb":["2540998-0"]},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 19.01.2017"]} | ||
| SRT | |a ROHLFINGSANONPEGYLAT2015 | ||